KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Merck (MRK) Equity Ratio (2016 - 2025)

Merck (MRK) has disclosed Equity Ratio for 17 consecutive years, with 0.42 as the latest value for Q2 2025.

  • On a quarterly basis, Equity Ratio changed N/A to 0.42 in Q2 2025 year-over-year; TTM through Jun 2025 was 0.42, a N/A change, with the full-year FY2024 number at 0.4, up 12.24% from a year prior.
  • Equity Ratio was 0.42 for Q2 2025 at Merck, up from 0.4 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.44 in Q1 2023 to a low of 0.3 in Q1 2021.
  • A 5-year average of 0.39 and a median of 0.39 in 2023 define the central range for Equity Ratio.
  • Peak YoY movement for Equity Ratio: skyrocketed 30.5% in 2021, then fell 16.38% in 2023.
  • Merck's Equity Ratio stood at 0.36 in 2021, then increased by 16.57% to 0.42 in 2022, then dropped by 16.38% to 0.35 in 2023, then increased by 12.24% to 0.4 in 2024, then grew by 5.42% to 0.42 in 2025.
  • Per Business Quant, the three most recent readings for MRK's Equity Ratio are 0.42 (Q2 2025), 0.4 (Q4 2024), and 0.35 (Q4 2023).